CYTOKINE PROFILE FEATURES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Objective. To determine the information content of the cytokine profile (IL-1β, IL-2 and IL-6) in predicting complications in patients with myocardial infarction (MI) against the background of chronic obstructive pulmonary disease (COPD).Materials and methods. In 85 people were examined: 28 patients with myocardial infarction, 37 patients with comorbid pathology (MI + COPD) and 20 somatically healthy volunteers as a control group. Determination of IL-1β, IL-2 and IL-6 levels was basing on enzyme immunoassay.Results. When assessing the cytokine profile in patients with MI and MI against the background of COPD, the most pronounced differences between groups of patients were observed in the levels of IL-6. Analyzing the association of the level of IL-6 with the presence of early complications of MI, it was found that the level of IL-6 in patients with complicated MI was significantly higher than in patients with uncomplicated course. The highest level of IL-6 was recorded in the subgroup of patients with complicated myocardial infarction during COPD. Studying the levels of IL-6 depending on the type of complications of myocardial infarction showed that the highest values of IL-6 were recorded in the group of comorbid patients with cardiogenic shock and pulmonary edema.Conclusion. When determining the cytokine status in patients with myocardial infarction on the background of COPD, the level of IL-6 should be considered as the main indicator. This cytokine can be considered a marker of left ventricular that developed in the acute period in patients with myocardial infarction on the background of COPD.

Download Full-text

Serum cytokine profile in stable patients with work8related chronic obstructive pulmonary disease and relationship to other inflammatory markers

Russian Pulmonology ◽

10.18093/0869-0189-2015-25-5-566-573 ◽

2015 ◽

Vol 25 (5) ◽

pp. 566-573 ◽

Cited By ~ 1

Author(s):

T. V. Blinova ◽

L. A. Strakhova ◽

N. A. Lavrenyuk ◽

I. A. Umnyagina

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inflammatory Markers ◽

Cytokine Profile ◽

Chronic Obstructive ◽

Serum Cytokine ◽

Obstructive Pulmonary Disease

Download Full-text

Oral and Oropharyngeal Sensory Function in Adults With Chronic Obstructive Pulmonary Disease

American Journal of Speech-Language Pathology ◽

10.1044/2019_ajslp-19-00095 ◽

2020 ◽

Vol 29 (2) ◽

pp. 864-872

Author(s):

Fernanda Borowsky da Rosa ◽

Adriane Schmidt Pasqualoto ◽

Catriona M. Steele ◽

Renata Mancopes

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Oral Cavity ◽

Pulmonary Disease ◽

Thermal Sensation ◽

Sensory Function ◽

Control Group ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Age Related ◽

Copd Patients

Introduction The oral cavity and pharynx have a rich sensory system composed of specialized receptors. The integrity of oropharyngeal sensation is thought to be fundamental for safe and efficient swallowing. Chronic obstructive pulmonary disease (COPD) patients are at risk for oropharyngeal sensory impairment due to frequent use of inhaled medications and comorbidities including gastroesophageal reflux disease. Objective This study aimed to describe and compare oral and oropharyngeal sensory function measured using noninstrumental clinical methods in adults with COPD and healthy controls. Method Participants included 27 adults (18 men, nine women) with a diagnosis of COPD and a mean age of 66.56 years ( SD = 8.68). The control group comprised 11 healthy adults (five men, six women) with a mean age of 60.09 years ( SD = 11.57). Spirometry measures confirmed reduced functional expiratory volumes (% predicted) in the COPD patients compared to the control participants. All participants completed a case history interview and underwent clinical evaluation of oral and oropharyngeal sensation by a speech-language pathologist. The sensory evaluation explored the detection of tactile and temperature stimuli delivered by cotton swab to six locations in the oral cavity and two in the oropharynx as well as identification of the taste of stimuli administered in 5-ml boluses to the mouth. Analyses explored the frequencies of accurate responses regarding stimulus location, temperature and taste between groups, and between age groups (“≤ 65 years” and “> 65 years”) within the COPD cohort. Results We found significantly higher frequencies of reported use of inhaled medications ( p < .001) and xerostomia ( p = .003) in the COPD cohort. Oral cavity thermal sensation ( p = .009) was reduced in the COPD participants, and a significant age-related decline in gustatory sensation was found in the COPD group ( p = .018). Conclusion This study found that most of the measures of oral and oropharyngeal sensation remained intact in the COPD group. Oral thermal sensation was impaired in individuals with COPD, and reduced gustatory sensation was observed in the older COPD participants. Possible links between these results and the use of inhaled medication by individuals with COPD are discussed.

Download Full-text